Latest News-SEEGENE Mediaroom_Page

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

* Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu ...

2022-04-06 20:08 1996

Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary

SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 0965...

2022-03-17 20:00 1354

Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business

SEOUL, South Korea, March 2, 2022 /PRNewswire/ -- Seegene Inc. (KQ 09653...

2022-03-02 20:00 1334

Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era

SEOUL, South Korea, Feb. 24, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2022-02-24 20:00 2000

Seegene Announces Q4 and Full-Year 2021 Financial Results

* Total sales of 2021 stood at KRW 1.37 trillion, a 22% increase YoY * Q4 Revenue of KRW 410 bil...

2022-02-17 20:00 2169

Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil

SEOUL, South Korea, Feb. 10, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2022-02-10 20:00 2185

Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing

SEOUL, South Korea, Jan. 19, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2022-01-19 20:00 1599

Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing

Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2022-01-17 20:00 2248

Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2022-01-17 20:00 2418

Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference

SEOUL, South Korea, Jan. 13, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2022-01-13 04:00 2593

Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane

* On December 29, Seegene to deliver Allplex™ SARS-CoV-2 Master Assay that can preemptively detec...

2021-12-29 19:00 3565

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading mo...

2021-12-09 20:18 1869

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading m...

2021-11-30 19:25 2140

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

* Q3 Revenue held steady at KRW 305.3 billion * Operating profit dipped slight due to powerful i...

2021-11-23 16:03 1615

Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing

SEOUL, South Korea, Nov. 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology...

2021-11-15 19:00 1408

Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

* A true walk away 'sample to answer' molecular diagnostic system designed for high throughput tes...

2021-10-27 23:40 1747

Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus

* Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including ...

2021-07-13 20:00 1380

Latest News